Dyadic mindfulness for Parkinson's (NCT06821230)
Reduce depression anxiety and stress
- Trial ID
- NCT06821230
- Official Title
- Enhancing Psychological Wellbeing and the Patient-caregiver Relationship Through Dyadic Mindfulness: A Randomized Controlled Trial in People With Parkinson's Disease and Their Caregivers
- Goal
- Reduce depression anxiety and stress
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- The University of Hong Kong
- Study Type
- INTERVENTIONAL
- Enrollment
- 200 participants
- Conditions
- Mindfulness, Caregivers, Movement Disorders, Neurodegenerative Disease, Dyadic Intervention, Psychosocial Health, Parkinsons Disease
- Interventions
- Dyadic mindfulness
Summary For Families
Aims to boost psychological wellbeing and strengthen the patient-caregiver relationship for people with mild to moderate Parkinson's who are experiencing at least mild depression, anxiety, or stress. It offers a dyadic mindfulness program where the person with PD and their primary caregiver learn guided attention, breathing, and emotion-regulation practices together to reduce stress and low mood, improve communication and empathy, and provide coping tools that complement medications rather than replace them. Looking for Cantonese-speaking patient-caregiver pairs, with patients aged 50 to 80, Hoehn and Yahr stage I to III, and at least one DASS-21 threshold met (depression ≥10, anxiety ≥8, or stress ≥15). Excludes pairs already doing regular supervised mind-body practice more than twice weekly, those with acute psychosis, significant cognitive impairment, current participation in other trials, or major hearing/vision problems that would limit participation.
Locations
- School of Nursing, The University of Hong Kong, Hong Kong, Hong Kong
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Dyadic mindfulness. Aims to boost psychological wellbeing and strengthen the patient-caregiver relationship for people with mild to moderate Parkinson's who are experiencing at least mild depression, anxiety, or stress. It offers a dyadic mindfulness program where the person with PD and their primary caregiver learn guided attention, breathing, and emotion-regulation practices together to reduce stress and low mood, improve communication and empathy, and provide coping tools that complement medications rather than replace them. Looking for Cantonese-speaking patient-caregiver pairs, with patients aged 50 to 80, Hoehn and Yahr stage I to III, and at least one DASS-21 threshold met (depression ≥10, anxiety ≥8, or stress ≥15). Excludes pairs already doing regular supervised mind-body practice more than twice weekly, those with acute psychosis, significant cognitive impairment, current participation in other trials, or major hearing/vision problems that would limit participation.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 2 years and 5 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This trial has a group that receives no study treatment (you would continue your usual care) alongside the treatment group. Because assignment is random, you have about a 1 in 2 chance (roughly 50%) of being in the no-treatment group, assuming the groups are filled equally. Ask the coordinator to confirm the exact assignment ratio.
- How many visits does this trial involve?
- Assessments will occur at baseline (T0), post-intervention (T1), and 4-months post-intervention (T2).